Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Aptevo Therapeutics Gross Profit 2014-2019 | APVO

Aptevo Therapeutics gross profit from 2014 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Aptevo Therapeutics Annual Gross Profit
(Millions of US $)
2018 $12
2017 $10
2016 $-2
2015 $17
2014 $29
2013 $
Aptevo Therapeutics Quarterly Gross Profit
(Millions of US $)
Q3 2019 $5
Q2 2019 $1
Q1 2019 $3
Q4 2018 $2
Q3 2018 $3
Q2 2018 $4
Q1 2018 $2
Q4 2017 $1
Q3 2017 $4
Q2 2017 $1
Q1 2017 $4
Q4 2016 $-9
Q3 2016 $-1
Q2 2016 $4
Q1 2016 $5
Q4 2015
Q3 2015 $3
Q2 2015 $3
Q4 2014
Q4 2013
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.023B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.537B 14.47
Gilead Sciences (GILD) United States $94.394B 12.17
CSL (CSLLY) Australia $92.258B 0.00
Vertex Pharmaceuticals (VRTX) United States $60.161B 54.60
Biogen (BIIB) United States $56.997B 9.73
Regeneron Pharmaceuticals (REGN) United States $50.379B 21.34
Illumina (ILMN) United States $40.381B 41.75
Alexion Pharmaceuticals (ALXN) United States $20.984B 9.76
Seattle Genetics (SGEN) United States $19.312B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.902B 36.26
BioMarin Pharmaceutical (BMRN) United States $16.385B 701.69
Galapagos (GLPG) Belgium $15.127B 33.04
Genmab (GNMSF) Denmark $14.806B 47.62
Alnylam Pharmaceuticals (ALNY) United States $13.291B 0.00
Exact Sciences (EXAS) United States $11.950B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
Moderna (MRNA) United States $9.813B 0.00
BeiGene (BGNE) Cayman Islands $9.652B 0.00
Sarepta Therapeutics (SRPT) United States $8.470B 0.00
QIAGEN (QGEN) Netherlands $7.913B 24.37
Guardant Health (GH) United States $7.653B 0.00
BioNTech SE (BNTX) Germany $7.636B 0.00
Bio-Techne Corp (TECH) United States $7.587B 51.92
Horizon Therapeutics Public (HZNP) Ireland $6.580B 17.65
ACADIA Pharmaceuticals (ACAD) United States $6.195B 0.00
Ascendis Pharma (ASND) Denmark $6.195B 0.00
Reata Pharmaceuticals (RETA) United States $6.012B 0.00
Amarin (AMRN) Ireland $5.812B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.736B 0.00
Exelixis (EXEL) United States $5.708B 18.32
Acceleron Pharma (XLRN) United States $4.637B 0.00
China Biologic Products (CBPO) China $4.555B 25.66
Repligen (RGEN) United States $4.433B 81.11
Bluebird Bio (BLUE) United States $4.043B 0.00
Global Blood Therapeutics (GBT) United States $3.928B 0.00
Adaptive Biotechnologies (ADPT) United States $3.687B 0.00
MorphoSys AG (MOR) Germany $3.577B 0.00
Mirati Therapeutics (MRTX) United States $3.497B 0.00
Zai Lab (ZLAB) China $3.360B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.225B 0.00
Alkermes (ALKS) Ireland $3.197B 253.25
Immunomedics (IMMU) United States $3.164B 0.00
NeoGenomics (NEO) United States $3.131B 166.61
Blueprint Medicines (BPMC) United States $3.110B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.096B 52.45
Genmab (GMAB) Denmark $3.090B 12.12
Momenta Pharmaceuticals (MNTA) United States $3.042B 0.00
Emergent Biosolutions (EBS) United States $3.038B 21.09
MyoKardia (MYOK) United States $2.981B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.948B 0.00
Halozyme Therapeutics (HALO) United States $2.926B 0.00
Amicus Therapeutics (FOLD) United States $2.510B 0.00
Fate Therapeutics (FATE) United States $2.410B 0.00
Insmed (INSM) United States $2.363B 0.00
Arena Pharmaceuticals (ARNA) United States $2.345B 6.12
UniQure (QURE) Netherlands $2.336B 0.00
Principia Biopharma (PRNB) United States $2.217B 0.00
RA PHARMCTL INC (RARX) United States $2.200B 0.00
Denali Therapeutics (DNLI) United States $2.077B 0.00
Epizyme (EPZM) United States $1.971B 0.00
Alector (ALEC) United States $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.802B 52.63
Eidos Therapeutics (EIDX) United States $1.801B 0.00
REGENXBIO (RGNX) United States $1.748B 0.00
Akcea Therapeutics (AKCA) United States $1.683B 38.96
Arvinas (ARVN) United States $1.638B 0.00
Zymeworks (ZYME) Canada $1.593B 0.00
Coherus BioSciences (CHRS) United States $1.429B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.391B 0.00
Zealand Pharma (ZEAL) Denmark $1.343B 0.00
Myriad Genetics (MYGN) United States $1.337B 23.59
Nabriva Therapeutics AG (NBRV) Ireland $1.295B 0.00
Intra-Cellular Therapies (ITCI) United States $1.233B 0.00
Editas Medicine (EDIT) United States $1.150B 0.00
Revance Therapeutics (RVNC) United States $1.125B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.105B 0.00
Twist Bioscience (TWST) United States $1.089B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Athenex (ATNX) United States $1.000B 0.00
PHARMA MAR SA (PHMMF) Spain $0.914B 0.00
DBV Technologies S.A (DBVT) France $0.906B 0.00
Mesoblast (MESO) Australia $0.885B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.834B 0.00
Cytokineticsorporated (CYTK) United States $0.831B 0.00
Sangamo Therapeutics (SGMO) United States $0.799B 0.00
Heska (HSKA) United States $0.780B 0.00
Codexis (CDXS) United States $0.760B 0.00
Intrexon (PGEN) United States $0.721B 0.00
ANI Pharmaceuticals (ANIP) United States $0.717B 12.23
Cellectis S.A (CLLS) France $0.711B 0.00
Arcus Biosciences (RCUS) United States $0.700B 0.00
Vericel (VCEL) United States $0.676B 100.27
Retrophin (RTRX) United States $0.659B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.635B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.604B 5.34
Anika Therapeutics (ANIK) United States $0.603B 20.61
Intellia Therapeutics (NTLA) United States $0.601B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
UROGEN PHARMA (URGN) United States $0.594B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.587B 0.00
Kadmon Holdings (KDMN) United States $0.575B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
AC Immune SA (ACIU) Switzerland $0.494B 11.42
Aquinox Pharmaceuticals (NLTX) United States $0.486B 0.00
NantKwest (NK) United States $0.485B 0.00
Prothena (PRTA) Ireland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
BioDelivery Sciences (BDSI) United States $0.441B 0.00
Cue Biopharma (CUE) United States $0.435B 0.00
Compugen (CGEN) Israel $0.433B 0.00
AnaptysBio (ANAB) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.413B 0.00
Clovis Oncology (CLVS) United States $0.410B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Agenus (AGEN) United States $0.405B 0.00
Inovio Pharmaceuticals (INO) United States $0.404B 0.00
Pfenex (PFNX) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.397B 0.00
Cel-Sci (CVM) United States $0.395B 0.00
Kindred Biosciences (KIN) United States $0.394B 0.00
PDL BioPharma (PDLI) United States $0.387B 9.69
Sorrento Therapeutics (SRNE) United States $0.376B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.373B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.367B 0.00
Avid Bioservices (CDMO) United States $0.366B 0.00
Dynavax Technologies (DVAX) United States $0.361B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Gritstone Oncology (GRTS) United States $0.318B 0.00
Stemline Therapeutics (STML) United States $0.307B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
MannKind (MNKD) United States $0.297B 0.00
Novavax (NVAX) United States $0.296B 0.00
Albireo Pharma (ALBO) United States $0.296B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.294B 0.00
WAVE Life Sciences (WVE) Singapore $0.290B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.281B 0.00
Aduro Biotech (ADRO) United States $0.275B 0.00
Kamada (KMDA) Israel $0.273B 11.37
Syros Pharmaceuticals (SYRS) United States $0.273B 0.00
Starpharma Holdings (SPHRY) Australia $0.272B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
IVERIC Bio (ISEE) United States $0.232B 0.00
Geron (GERN) United States $0.228B 0.00
VBI Vaccines (VBIV) United States $0.226B 0.00
Protagonist Therapeutics (PTGX) United States $0.226B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Prometic Life Sciences (LMNL) Canada $0.216B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
XOMA (XOMA) United States $0.212B 0.00
Alcobra (ARCT) United States $0.212B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.209B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
TELA Bio (TELA) United States $0.199B 0.00
Athersys (ATHX) United States $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.187B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.183B 0.00
VTv Therapeutics (VTVT) United States $0.180B 0.00
Cerecor (CERC) United States $0.177B 0.00
Five Prime Therapeutics (FPRX) United States $0.176B 0.00
Arbutus Biopharma (ABUS) Canada $0.174B 0.00
VolitionRX (VNRX) Singapore $0.173B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.169B 8.69
Exicure (XCUR) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Fortress Biotech (FBIO) United States $0.163B 0.00
Selecta Biosciences (SELB) United States $0.159B 0.00
Verastem (VSTM) United States $0.149B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Dyadic (DYAI) United States $0.143B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Arsanis (XFOR) United States $0.137B 0.00
Aptinyx (APTX) United States $0.137B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
ARAVIVE, INC (ARAV) United States $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.130B 0.00
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
Palatin Technologies (PTN) United States $0.118B 3.22
Happiness Biotech Group (HAPP) China $0.117B 0.00
OvaScience (MLND) United States $0.117B 0.00
Clearside Biomedical (CLSD) United States $0.111B 0.00
Vaccinex (VCNX) United States $0.110B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.102B 0.00
AIT Therapeutics (XAIR) United States $0.102B 0.00
Applied Genetic Technologies (AGTC) United States $0.090B 0.00
Adocia (ADOCY) France $0.086B 0.00
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.080B 0.00
Catalyst Biosciences (CBIO) United States $0.074B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Menlo Therapeutics (MNLO) United States $0.073B 0.00
Pluristem Therapeutics (PSTI) Israel $0.073B 0.00
Orgenesis (ORGS) United States $0.070B 4.52
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Trevena (TRVN) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.063B 0.00
DiaMedica Therapeutics (DMAC) United States $0.061B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Soligenix (SNGX) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.054B 16.49
Advaxis (ADXS) United States $0.054B 0.00
Protalix BioTherapeutics (PLX) Israel $0.053B 0.00
NewLink Genetics (NLNK) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.042B 0.00
TOCAGEN INC (TOCA) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Cleveland BioLabs (CBLI) United States $0.038B 0.00
Curis (CRIS) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Celsion (CLSN) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
IBio (IBIO) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
VIVUS (VVUS) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00